Here is the “Deal Flow (Summary of Bulk & Block Deals)” of the data that is revealed in the markets. This has been collated and curated to make trade-able sense.
A Bulk Deal is a trade, where total quantity bought or sold is more than 0.5% of the number of equity shares of the company. A trade, with a minimum quantity of 5,00,000 shares or minimum value of Rs.5 crore executed through a single transaction on this separate window of the stock exchange will constitute a Block Deal.
Borosil Glass Works
The company is the market leader for laboratory glassware and microwavable kitchenware in India with a significant presence in USA, Netherlands and in India.
Hindustan Composites which held 135,000 shares or 4.49% as of December, 2015 – sold 81,461 shares or 2.71% to reduce its stake to 53,539 shares or 1.78%
Hindustan Composites is a pioneer in the development, manufacture & marketing of Asbestos Industrial Products and Friction Materials in India for over 50 years.
Composites, with its wide range of products suitable for a number of general and specialised applications, has been catering to the diversified needs of core sector industries, such as Railways, Engineering, Mining, Aerospace, Steel, Chemical, Petrochemical, Fertilizer, Power Generation, Ship Building, Atomic Energy, Electrical, Oil Exploration, Automotive, etc.
India Opportunities Growth Fund – Pinewood Strategy – a Mauritius based entity purchased 80,885 shares or 2.69%.
Shilpa Medicare
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989.
Shilpa Medicare has gained World Health Organization-Good Manufacturing Practices (GMP) Certificate recognition. In our relentless efforts for growth-Shilpa Medicare successfully set up a 100% EOU project in FY10 incurring a capital expenditure of nearly Rs.1000 million. Its subsidiaries include – LobaFienchem, Raichem Life Sciences, Nu Therapeutics, and Reva Pharma
Shilpa Medicare’s facilities have received key regulatory approvals for its facilities as well as for the products from EDQM, UK-MHRA, TGA, USFDA, PMDA and KFDA.
Standard Chartered Bank (Mauritius) sold its entire stake of 2,573,278 shares or 3.34% to CLSA (Credit Lyonnais Securities Asia) Global Markets.
Check out the Deal Flow for the other days:
Deal Flow – 11/02: Nordea follows SBI Life Insurance and exits Justdial
Disclaimer
Nothing in this newsletter is financial advice and should not be construed as such. Please do not take trading decisions based solely on the matter above; if you do, it is entirely at your own risk without any liability to Capital Mind. This is educational or informational matter only, and is provided as an opinion.
